Align Technology | ALGN - Operating Profit

Stock Price
161.30
Daily Change
4.25 2.71%
Monthly
0.73%
Yearly
-25.45%
Q1 Forecast
158.01

Align Technology reported $184.65M in Operating Profit for its fiscal quarter ending in September of 2025.





Operating Profit Change Date
3M USD 1.21B 394M Dec/2025
Align Technology USD 184.65M 21.61M Sep/2025
Becton, Dickinson and Co. USD 826M 153M Sep/2025
Bruker USD 83.9M 72M Sep/2025
Cardinal Health USD 754M 125M Sep/2025
Charles River Laboratories USD 133.8M 1.46M Sep/2025
Cooper Companies USD 140.4M 35.3M Sep/2025
CVS Health USD 2.95B 339M Sep/2025
Danaher USD 1.5B 348M Dec/2025
Dentsply International USD 512M 401M Sep/2025
Dexcom USD 242.5M 29.9M Sep/2025
Henry Schein USD 198M 22M Sep/2025
Idexx Laboratories USD 315.6M 39.24M Dec/2025
Insulet USD 117.7M 3.4M Sep/2025
Integra LifeSciences USD 11.76M 13.07M Sep/2025
IQVIA Holdings USD 573M 17M Sep/2025
Masimo USD 83.6M 19.1M Sep/2025
McKesson USD 1.5B 413M Sep/2025
Mettler Toledo International USD 294.2M 28.49M Sep/2025
Revvity USD 98.34M 8.63M Sep/2025
Solventum Corp USD 1.69B 1.47B Sep/2025
Stryker USD 1.97B 609M Dec/2025
Teleflex USD -408.9M 586.38M Sep/2025
Thermo Fisher Scientific USD 2.3B 226M Dec/2025
Veeva Systems USD 240.85M 14.32M Sep/2025
Waters USD 192.11M 3.9M Sep/2025
Zimmer Biomet Holdings USD 338.3M 58.1M Sep/2025
Zoetis USD 936M 63M Sep/2025